News
- Author:
- Ted Bosworth
Publish date: March 30, 2022
“Cellulitis is misdiagnosed about one-third of the time, and that cost is very high,” reported Jennifer L. Adams, MD.
News
- Author:
- Ted Bosworth
Publish date: March 29, 2022
Retronychia is usually a clinical diagnosis based on the presence of the increased bulk of the toenail when overlapping nails cannot be seen.
News
- Author:
- Ted Bosworth
Publish date: March 29, 2022
The effect in treated patients was sustained when reevaluated at 12 months.
News
- Author:
- Ted Bosworth
Publish date: March 26, 2022
“The process is the product,” according to Terrence Keaney, MD.
News
- Author:
- Ted Bosworth
Publish date: March 15, 2022
More than 18 months after approval, the Watchman FLX left atrial appendage closure device is performing well at 45 days in real-world use.
News
- Author:
- Ted Bosworth
Publish date: March 4, 2022
When compared with regular menstrual cycles, irregular cycles were associated with nonalcoholic fatty liver disease in a study, but experts are ske...
News
- Author:
- Ted Bosworth
Publish date: March 1, 2022
Portable electronics embedded with magnets powerful enough to impair CV device functions are proliferating.
News
- Author:
- Ted Bosworth
Publish date: February 10, 2022
In psoriatic arthritis patients with axial involvement, researchers saw sustained improvement with guselkumab through 100 weeks on all outcomes emp...
News
- Author:
- Ted Bosworth
Publish date: February 9, 2022
JAK inhibitors’ discontinuation and retention rates were similar to those for other biologic disease-modifying antirheumatic drugs, including tumor...
News
- Author:
- Ted Bosworth
Publish date: February 8, 2022
In real-world study, stem cell transplant provides major advantages for rapidly progressive systemic sclerosis if strict selection criteria are use...
News
- Author:
- Ted Bosworth
Publish date: February 7, 2022
Relative to controls, the increased long-term cardiovascular risk of patients with Kawasaki disease is small in most patients.
News
- Author:
- Ted Bosworth
Publish date: January 24, 2022
After onset of non-STEMI symptoms, delays in hospitalization are linked to poorer long-term outcomes.
News
- Author:
- Ted Bosworth
Publish date: November 24, 2021
Daily aspirin may need to be reconsidered in those at risk of heart failure, based on evidence of an association.
News
- Author:
- Ted Bosworth
Publish date: November 17, 2021
The monoclonal antibody bentracimab, which can rapidly reverse ticagrelor, was found effective and safe in an FDA-requested interim analysis of a p...
News
- Author:
- Ted Bosworth
Publish date: November 16, 2021
Despite zero evidence of benefit on the primary endpoint, stem cell transplant is still promising in heart failure.
